Works matching AU Bonavia, Marco


Results: 7
    1

    Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.

    Published in:
    Biomedicines, 2023, v. 11, n. 9, p. 2424, doi. 10.3390/biomedicines11092424
    By:
    • Bagnasco, Diego;
    • Nicola, Stefania;
    • Testino, Elisa;
    • Brussino, Luisa;
    • Pini, Laura;
    • Caminati, Marco;
    • Piccardo, Federica;
    • Canevari, Rikki Frank;
    • Melissari, Laura;
    • Ioppi, Alessandro;
    • Guastini, Luca;
    • Lombardi, Carlo;
    • Milanese, Manlio;
    • Losa, Francesca;
    • Robbiano, Michela;
    • De Ferrari, Laura;
    • Riccio, Anna Maria;
    • Guida, Giuseppe;
    • Bonavia, Marco;
    • Fini, Donatella
    Publication type:
    Article
    2
    3
    4
    5
    6

    The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real life.

    Published in:
    Allergy, 2020, v. 75, n. 6, p. 1460, doi. 10.1111/all.14135
    By:
    • Bagnasco, Diego;
    • Massolo, Alessandro;
    • Bonavia, Marco;
    • Brussino, Luisa;
    • Bucca, Caterina;
    • Caminati, Marco;
    • Canonica, Giorgio Walter;
    • Caruso, Cristiano;
    • D'Amato, Maria;
    • De Ferrari, Laura;
    • Guida, Giuseppe;
    • Heffler, Enrico;
    • Lombardi, Carlo;
    • Menzella, Francesco;
    • Milanese, Manlio;
    • Paoletti, Giovanni;
    • Riccio, Anna Maria;
    • Rolla, Giovanni;
    • Senna, Gianenrico;
    • Testino, Elisa
    Publication type:
    Article
    7